[299 Pages Report] The global platelet function test market is expected to be valued at US$ 1178.4 Million in 2022. With the growing prevalence of platelet abnormalities, the overall demand for platelet function tests is projected to grow at a CAGR of 6.3% between 2022 and 2032, totaling around US$ 2170.8 Million by 2032.
| Data Points | Key Statistics |
|---|---|
| Platelet Function Test Market Value 2022 | US$ 1,178.4 Million |
| Platelet Function Test Market Projected Value (2032) | US$ 2,170.8 Million |
| Platelet Function Test Market CAGR (2022 to 2032) | 6.3% |
Platelets are blood cells that are responsible for clotting broken blood arteries. Blood vessels are in charge of transporting blood throughout the body. When blood arteries are injured, platelets link together and clot the affected region, halting blood loss.
The clotting process begins when the injured arteries transmit signals that the platelets pick up on. Platelets go to the wounded location, restructure themselves to create a mesh, and bind to the damaged surface, preventing bleeding. A sufficient quantity of platelets is necessary for the human body for the clotting process to work properly.
In some situations, platelets cease to function effectively and lose their capacity to adhere to the injured region, therefore halting bleeding. These illnesses, which can be inherited or acquired, increase the patient's chance of death. These diseases include ineffective platelet adhesion, platelet aggregation, platelet secretion, pro-coagulant activity, and anomalies in platelet production, hence it is vital to monitor platelet function. Platelet function tests are intended to identify issues related to platelet generation and function in the blood.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for platelet function tests is projected to increase at a CAGR of 6.3% during the forecast period between 2022 and 2032, reaching a total of US$ 2,170.8 Million in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.2%.
A platelet function test is required to determine whether or not a person has a platelet function abnormality. Platelet function is essential for the entire body process. Platelet abnormalities and illnesses can be treated if detected early. As a result, these factors may present strong growth possibilities for the platelet function test market.
Platelet problems such as thrombocytopenia and thrombocythemia are becoming more common, which may raise demand for platelet function tests throughout the projected period. The global elderly population is likewise growing at a rapid pace. As a result, the platelet function test market may see attractive development possibilities as a result of this factor.
Growing Incidence of Platelet Disorders to Accelerate the Market Growth
The platelet function test is in high demand due to the growing incidence of platelet diseases. The rising prevalence of illnesses such as thrombocythemia (an abnormal rise in the number of platelets) and thrombocytopenia (a reduction in the number of platelets) is likely to drive the platelet function test market during the forecast period.
Platelet function abnormalities are 1.5 times more likely to develop in women and the senior population. With the growing worldwide life expectancy rate, there is an expansion in the patient pool requiring platelet function tests, which is predicted to increase demand for the platelet function test market. Because of the growing number of cancer patients, increased use of platelet treatment is likely to drive the platelet function test market.
Other factors such as an increase in surgical operations, more awareness, and the development of new technologies are projected to drive the platelet function test market.
Principal Consultant
Unfavorable Reimbursement Regulations to stymie the Market Growth
Platelet function test market expansion will be hampered by unfavorable reimbursement regulations in emerging nations. In addition, a lack of competent specialists or educated knowledge in developing and undeveloped economies may impede the development rate of the platelet function test market.
Region's Increased Awareness of Platelet-Related Illnesses to Fuel the Market Growth
The platelet function test market in North America is expected to accumulate the highest market share of 29% in 2022. North America has a larger regional share of the global platelet function test market.
North America is likely to lead the platelet function test market during the forecast period, owing to high platelet function test adoption rates and increased awareness of platelet-related illnesses. Furthermore, the existence of various manufacturers, as well as the growing pace of clinical research, is projected to drive platelet function test market expansion in this area.
Massive Patient Population in the Region to Fuel the Market Growth
The Platelet Function Test market in Asia is expected to accumulate a significant market share of 23% in 2022 and is expected to continue to maintain the trend over the forecast period as well.
The Asian market is predicted to have the highest market growth, owing to a massive patient population and manufacturers' development of inexpensive platelet function tests due to low taxation rates. The region's improved distribution channels and huge patient pool are also projected to drive the platelet function test market.
Increased Government Healthcare Spending in the Region to Accelerate Market
The platelet function test market in Europe is expected to accumulate a market share value of 27% in 2022. Europe is predicted to be an important market for platelet function tests, due to increased government healthcare spending and the implementation of efficient reforms for producers of platelet function test kits and systems.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Diagnostics Centers Segment to Drive the Platelet Function Test Market
The platelet function test market is divided into hospitals, blood banks, diagnostics centers, academic institutions, and others based on end-use. The diagnostics centers sector is expected to have the largest market by 2032. A crucial aspect driving this rise is the increasing availability of much user-friendly, portable, and precise testing equipment.
Start-ups and their innovations are driving some of the most recent advances in the platelet function test sector. Let's have a look at some of the primary start-ups in this industry:
F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Siemens AG, Accriva Diagnostics, Helena Laboratories, Terumo BCT, Inc., Fresenius SE & Co KGaA., and Aggredyne, Inc. are some of the main players in the platelet function test industry.
Companies are now concentrating on developing more accurate test methods and analyzers, as well as making ongoing efforts to build distribution channels in growing markets.
Recent Developments:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.3% from 2022 to 2032 |
| Market Value in 2022 | US$ 1,178.4 Million |
| Market Value in 2032 | US$ 2,170.8 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available upon Request |
By 2022-end, sales of platelet function test closed at a value of US$ 1178.4 Million
From 2017 to 2021, platelet function test demand expanded at a CAGR of 6.2%
From 2022 to 2032, platelet function test sales are expected to flourish at a CAGR of 6.3%
By 2032, the market value of platelet function test expected to reach US$ 2,170.8 Million
1. Executive Summary | Platelet Function Test Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2016 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2016 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2022 to 2032 5.3.1. Systems 5.3.2. Reagents 5.3.3. Accessories 5.4. Y-o-Y Growth Trend Analysis By Product, 2016 to 2021 5.5. Absolute $ Opportunity Analysis By Product, 2022 to 2032 6. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2016 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Hospitals 6.3.2. Blood Banks 6.3.3. Diagnostics Centers 6.3.4. Academic Institutions 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 7. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2016 to 2021 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032 7.3.1. Clinical Applications 7.3.2. Research Applications 7.3.3. Pharmaceutical Development 7.3.4. Other Applications 7.4. Y-o-Y Growth Trend Analysis By Application, 2016 to 2021 7.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032 8. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2016 to 2021 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia & Pacific 8.3.5. East Asia 8.3.6. Middle East & Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. The US 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By End User 9.2.4. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By End User 9.3.4. By Application 9.4. Key Takeaways 10. Latin America Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By End User 10.2.4. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By End User 10.3.4. By Application 10.4. Key Takeaways 11. Europe Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. The UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By End User 11.2.4. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By End User 11.3.4. By Application 11.4. Key Takeaways 12. South Asia & Pacific Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Australia 12.2.1.6. New Zealand 12.2.1.7. Rest of South Asia & Pacific 12.2.2. By Product 12.2.3. By End User 12.2.4. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By End User 12.3.4. By Application 12.4. Key Takeaways 13. East Asia Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By End User 13.2.4. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By End User 13.3.4. By Application 13.4. Key Takeaways 14. MEA Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product 14.2.3. By End User 14.2.4. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By End User 14.3.4. By Application 14.4. Key Takeaways 15. Key Countries Platelet Function Test Market Analysis 15.1. The US 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Product 15.1.2.2. By End User 15.1.2.3. By Application 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Product 15.2.2.2. By End User 15.2.2.3. By Application 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Product 15.3.2.2. By End User 15.3.2.3. By Application 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Product 15.4.2.2. By End User 15.4.2.3. By Application 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Product 15.5.2.2. By End User 15.5.2.3. By Application 15.6. The UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Product 15.6.2.2. By End User 15.6.2.3. By Application 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Product 15.7.2.2. By End User 15.7.2.3. By Application 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Product 15.8.2.2. By End User 15.8.2.3. By Application 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Product 15.9.2.2. By End User 15.9.2.3. By Application 15.10. India 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Product 15.10.2.2. By End User 15.10.2.3. By Application 15.11. Malaysia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Product 15.11.2.2. By End User 15.11.2.3. By Application 15.12. Singapore 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Product 15.12.2.2. By End User 15.12.2.3. By Application 15.13. Thailand 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Product 15.13.2.2. By End User 15.13.2.3. By Application 15.14. China 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Product 15.14.2.2. By End User 15.14.2.3. By Application 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Product 15.15.2.2. By End User 15.15.2.3. By Application 15.16. South Korea 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Product 15.16.2.2. By End User 15.16.2.3. By Application 15.17. Australia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Product 15.17.2.2. By End User 15.17.2.3. By Application 15.18. New Zealand 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Product 15.18.2.2. By End User 15.18.2.3. By Application 15.19. GCC Countries 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Product 15.19.2.2. By End User 15.19.2.3. By Application 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Product 15.20.2.2. By End User 15.20.2.3. By Application 15.21. Israel 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2021 15.21.2.1. By Product 15.21.2.2. By End User 15.21.2.3. By Application 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By End User 16.3.4. By Application 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. F. Hoffmann-La Roche Ltd 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Haemonetics Corporation 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Siemens AG 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Helena Laboratories 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Terumo BCT 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Fresenius SE & Co KGaA 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Aggredyne, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. SENTINEL CH. SpA 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Drucker Diagnostics 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Thermo Fisher Scientific Inc. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Platelet Function Test Market
